Cycle Gear

Cycle Pharmaceuticals is a global pharmaceutical company headquartered in Cambridge, UK, specializing in the development and delivery of treatments for rare genetic and metabolic diseases. Founded in 2012, the company focuses on improving existing drug formulations to better serve patient needs, particularly through the use of innovative delivery technologies like orally disintegrating tablets. Their commercial portfolio includes Nityr for hereditary tyrosinemia type 1, Javygtor for phenylketonuria, and Tascenso ODT for multiple sclerosis. Cycle Pharmaceuticals is recognized for its patient-centric approach, providing comprehensive support services alongside its specialized therapeutic offerings. The company continues to expand its pipeline through internal development and strategic acquisitions within the rare disease space.